Form 4: Intuitive Surgical Director Amy L. Ladd Executes Stock Sale Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Director Amy L. Ladd sold 450 shares of Intuitive Surgical (ISRG) common stock at a price of $490.28 per share on September 13, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On September 13, 2024, Amy L. Ladd, a director of Intuitive Surgical Inc. (ISRG), sold 450 shares of the company's common stock.
  • The sale was executed at a price of $490.28 per share.
  • Following the transaction, Ladd directly owns 821 shares of Intuitive Surgical.
  • The transaction was conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1 and expires on July 25, 2025.
  • Ladd has granted power of attorney to several individuals at Intuitive Surgical and Latham & Watkins LLP to execute and file necessary SEC forms related to her transactions in the company's securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to a stock sale by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but it notes that the trading plan expires on July 25, 2025, suggesting continued transactions under the plan until that date.

Industry Context

Sales by company directors are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on non-public information.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, but given the relatively small number of shares sold and the pre-arranged nature of the transaction, the impact is likely to be minimal.

Key Dates

DateDescription
July 25, 2024Date of Power of Attorney execution.
July 25, 2025Expiration date of the 10b5-1 trading plan.
September 13, 2024Date of stock sale transaction.
September 16, 2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.